USD 444.54 mn growth for Dravet Syndrome Treatment Market by 2025

NEW YORK, Nov. 25, 2021 /PRNewswire/ — The “Dravet Syndrome Treatment Market – Competitive Analysis, Trends, Drivers, Challenges, and Five Force Analysis” report has been added to Technavio’s offering. The dravet syndrome treatment market size is expected to increase by USD 444.54 million, at a CAGR of 9.41% from 2020 to 2025. 39% of the market’s growth will originate from North America. The US and Canada are the key markets for the Dravet syndrome treatment market in North America.

For more insights on Dravet Syndrome Treatment Market – Download a free sample now!

Market Dynamics

The market is driven by factors such as the rising strategic alliances, increasing new product launches, and the growth in special regulatory designations. However, low awareness is hindering market growth.

Company Profiles

The dravet syndrome treatment market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market. Some of the companies covered in this report are AbbVie Inc., BIOCODEX SAS, Cadila Healthcare Ltd., Epygenix Therapeutics Inc., H. Lundbeck AS, PTC Therapeutics Inc., Supernus Pharmaceuticals Inc., Takeda Pharmaceutical Co. Ltd., and Zogenix Inc., etc.

Key Offerings of Few Companies –

• AbbVie Inc. – The company offers Stiripentol under the brand name of Diacomit which is used for the treatment of Dravet syndrome.

• BIOCODEX SAS – The company provides Brivaracetam tablets which help to cure Dravet syndrome.

• Cadila Healthcare Ltd – The company provides medicines such as EPX 100, 101, 102, 103, and others for the treatment of Dravet syndrome.

Competitive Analysis

The competitive scenario provided in the Dravet syndrome treatment market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc.

Story continues

Market Segmentation

• By Product, the market is classified into SGDs, TGDs, and FGDs.The dravet syndrome treatment market share growth by the SGDs segment has been significant

• By Geography, the market is classified as North America, Europe, Asia, and ROW. North America will have the largest share of the market.

Related Reports –
Sjogren’s Syndrome Therapeutics Market –The Sjogren’s syndrome therapeutics market size has the potential to grow by USD 287.68 million during 2021-2025, and the market’s growth momentum will accelerate at a CAGR of 4.05%. Download a free sample now!

Dry Eye Syndrome Drugs Market –The dry eye syndrome drugs market size has the potential to grow by USD 2.08 billion during 2021-2025, and the market’s growth momentum will accelerate at a CAGR of 6.81%. Download a free sample now!